India’s strategy on biosimilars and pricing comparisons with biologics
India is redefining biosimilars, balancing affordability and quality.
Healthcare & wellness News Portal
Pharmaceuticals & Healthcare Products
India is redefining biosimilars, balancing affordability and quality.
New regulations reshape how pharma brands connect online.
New reforms speed up access to innovative therapies.
India’s pharma sector faces key hurdles in IP enforcement.
Automation and AI are transforming pharma manufacturing efficiency.
India’s fight against antimicrobial resistance grows urgent.
India faces urgent reforms to restore trust in drug safety.
Pharma associations shape critical health policies today.
Increasing transparency in pricing boosts trust and safety.
Corporate social responsibility drives innovation in pharma.